healthcare · ASTERDM
Aster DM Healthcare
Aster DM Healthcare: PE above historical average. NARROW LEADERSHIP regime.
Price
₹814
Price 2026-07-30
5 day
+3.61%
Short-term move
1 month
+3.77%
Medium-term
Regime
NARROW LEADERSHIP
62% confidence
Market cap
₹40.8k Cr
neutral sector flow
Market Intelligence Analyst
Understand today's market in about 2 minutes.
“How does today's NARROW LEADERSHIP regime affect Aster DM Healthcare (ASTERDM) in the healthcare sector?”
Price chart
₹814
+37.31% over period
About Aster DM Healthcare
Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through four healthcare brands including Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care across key areas including oncology, cardiac sciences, neurosciences, gastro sciences, orthopedics, nephrology, organ transplantation, mother and childcare, and critical care. In addition, the company operates retail pharmacies and optical outlets. Aster DM Quality Care Limited was formerly known as Aster DM Healthcare Limited and changed its name to Aster DM Quality Care Limited in July 2026. The company was founded in 1987 and is based in Bengaluru, India.
At a Glance
RSI pattern warning
RSI oversold bounces for this stock succeeded only 0% of the time (avg -10.4% over 14 days) — not a reliable pattern.
52-week position
Trading at 97.3% of 52-week high
Technicals
RSI 14
52.2
Trend
uptrend
50 DMA
Above
200 DMA
Above
Key metrics
P/E ratio
104.9
43th pct · 7 quarterly points (limited history)
P/B
8.9
ROE
10.1%
Moderate profitability — 10.1% ROE
Market cap
₹40.8k Cr
Revenue growth
1820.0% YoY
Promoter
53.3%
52-week range
₹519.1 – ₹836.5
97.3% of high
RSI (14)
52.2
uptrend
vs 50 DMA
Above
DMA ₹783.69
Coverage
100/100
HIGH
Quick Take
Aster DM Healthcare: PE above historical average. NARROW LEADERSHIP regime.
Peer comparison
| Stock | Price | 5D | P/E | ROE | Rev growth | Mcap |
|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals | ₹8,988 | +1.4% | 65.4 | 21.5% | 1810% | ₹1.3L Cr |
| MAXHEALTH Max Healthcare | ₹1,124.8 | +3.7% | 76 | 14.3% | 1220% | ₹1.1L Cr |
| FORTIS Fortis Healthcare | ₹948.85 | +0.7% | 70.3 | 11% | 1780% | ₹73.4k Cr |
| NH Narayana Hrudayalaya | ₹2,080.3 | +4.9% | 50.2 | 19.8% | 7580% | ₹40.7k Cr |
| LALPATHLAB Dr. Lal Pathlabs | ₹1,878.8 | +11.7% | 55.7 | 21.5% | 1660% | ₹28.1k Cr |
| ASTERDM Aster DM Healthcare | ₹814 | +3.8% | 104.9 | 10.1% | 1820% | ₹40.8k Cr |
Tensions to watch
Promoter holding at 53.3% — neither distress selling nor aggressive buying
No strong insider signal. Watch for changes in promoter stake as a leading indicator.
Key Watchpoints
Breaks above ₹855 (+5%)
Trend reversal confirmation
Breaks below ₹773 (-5%)
Further downside risk
PE reverts to median of 104.9 (7 quarterly points (limited history))
Valuation normalization
Healthcare sector entering leadership
Sector rotation signal
